Reducing
Evidence-Practice Gaps
In Sickle Cell Disease
Measuring
Identifying Root Causes
Scaling Population-Level Interventions
About Decide4Health
We use implementation science and behavioral science to improve adherence to guideline-directed therapy, reducing preventable hospitalizations and costs for high-burden chronic diseases, starting with Sickle Cell Disease (SCD).
Our Team
Alex Morozov
CEO, Founder
Alex Morozov is a physician-scientist, drug developer and a writer with a passion for improving health outcomes. He spent about 15 years in the pharmaceutical industry overseeing hundreds of clinical trials of new cancer treatments. He is now focused on measuring, characterizing and ultimately reducing evidence-practice gaps.
Kevin Wake
Board Member
Kevin Wake is the former President of the Uriel E. Owens Sickle Cell Disease Association of the Midwest and an independent patient and sickle cell advocate. He brings invaluable experience from hospital patient and family advocacy councils and from working within the pharmaceutical industry. He serves on the Board of International Consortium of Health Outcome Measurement and other organizations.
Rebecca Seavers
Board Member
Rebecca Seavers is a mother of three grown children with Sickle Cell SC and two granddaughters with Sickle Cell SS. She has been an avid advocate of Sickle Cell Disease for over 30 years, currently serving as President of the Sickle Cell Association of Kentuckiana, a non-profit organization dedicated to helping families and children, and as Ambassador for Sick Cells, a leading national Sickle Cell Disease advocacy organization. She also serves on the West Louisville Chess Board, Pfizer Council for Sickle Cell Change and Norton Healthcare Sickle Cell Patient Family Advisory Council.
Paul Jeffrey
Board Member
Paul Jeffrey has served as senior director of Pharmacy for MassHealth, the Massachusetts Medicaid program , for over 30 years. In his role, Paul supported pharmacy business development for UMAss Chan Medical School, including developing and maintaining medication therapy management programs, evidence-based formularies, and clinical call centers. He has worked on several Sickle Cell Disease quality improvement programs.